Skip to content

IVCC publishes Annual Report 2024 to 2025

Annual Report 2024 - 2025 cover
Back
IVCC has published its Annual Report for 2024 to 2025, reflecting on a milestone year that marked 20 years of driving innovation in vector control.

The report highlights IVCC’s role in accelerating the development, evaluation, and adoption of new vector control tools to protect communities from malaria. Over the past two decades, IVCC has worked with countries, industry, researchers, and global health partners to move innovation from discovery into real-world use.

A central theme of the report is innovation to address growing challenges such as insecticide resistance, changing mosquito behaviour, and climate change. IVCC’s work spans four technology pillars, including insecticide-treated nets, indoor residual spraying, spatial emanators, and tools to prevent outdoor transmission. The report outlines progress across each area, with a strong focus on developing new modes of action and strengthening resistance management.

Reflecting on the year, Justin McBeath, Chief Executive Officer of IVCC, said: “In 2025, IVCC marked two decades of service to the malaria vector control community. The past year has been one of significant change both within IVCC and across the broader global health landscape. Despite the considerable changes experienced over the past year, IVCC remains strategically focused and well positioned to deliver on its mission – to leverage the value of the Product Development Partnership (PDP) model to accelerate innovation, catalyse access to transformative tools such as spatial emanators and ensure vector control interventions continue to save lives.”

The report also sets out the scale of impact delivered by vector control. New analysis from the Malaria Atlas Project confirms that vector control has been responsible for averting over one billion malaria cases in Africa since 2000, preventing millions of deaths and delivering strong returns on investment for health systems.

Partnerships remain central to IVCC’s approach. IVCC has expanded collaboration with national malaria programmes, industry partners, and research institutions across Africa and the Indo-Pacific. The report highlights efforts to support country-led delivery, strengthen domestic financing, and improve value for money in malaria control.

The Annual Report also reflects on a year of change across the global health landscape. IVCC maintained its strategic focus and continued delivery across its portfolio, supported by strong partnerships.

The Annual Report 2024 to 2025 is available to read in full here.

Related news

Registered office: Liverpool School Of Tropical Medicine, Pembroke Place, Liverpool, Merseyside, L3 5QA.

Registered in England and Wales.

Company number: 06719882
Registered Charity Number: 1128437

Useful

Policies

Back To Top
No results found...